Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model.
Amir M MoharebArthur Y KimAnders BoydFarzad NoubaryMenan Gérard KouaméXavier AnglaretPatrick A CoffieSerge Paul EholieKenneth A FreedbergEmily P HylePublished in: BMJ open (2024)
We simulated HBV DNA-stratified clinical outcomes with the novel HEPA-B Model and validated them to observational data. This model can be used to examine strategies of HBV prevention and management.
Keyphrases